A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects
Clinical trial NCT07043634 · COMPLETED
Trial details
- NCT number
- NCT07043634
- Sponsor
- Sarfez Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-15
- Primary completion
- 2025-12-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.